Overview: HbD TestIntroduction: The HbD Test tests for hemoglobin D to diagnose HbD disease, causing mild anemia or fatigue, helping manage blood disorders. Affecting 1 in 1,000 people of South Asian descent, HbD disease poses diagnostic challenges due to subtle presentation. Following 2023 American Society of Hematology (ASH) guidelines, it uses electrophoresis for high accuracy, supporting hematology screening. This test is vital for diagnosis, monitoring, and improving outcomes in hematology.
Other Names: Hemoglobin D Test, HbD Disease Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: Hemoglobin variant testing began in the 1950s with research by Itano, who identified HbD. Electrophoresis advancements in the 1970s by Helena Laboratories improved detection, surpassing earlier solubility tests.
Purpose: Detects hemoglobin D to diagnose HbD disease, guides blood management, and evaluates patients with fatigue, aiming to prevent complications.
Test Parameters: Hemoglobin D presence
Pretest Condition: No special preparation required. Collect whole blood. Report history of blood disorders.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document mild anemia or fatigue. Include current medications or transfusion history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., anemia), and sample collection risks.
Procedural Considerations: Uses electrophoresis to detect HbD, requiring labs with electrophoresis equipment. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or degradation can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive HbD confirms disease, guiding management. Early monitoring might prevent complications, while untreated cases lead to worsening. Normal results may require other hemoglobin tests.
Specialist Consultation: Consult a hematologist for interpretation.
Additional Supporting Tests: Complete blood count, hemoglobin electrophoresis, or genetic panel to confirm diagnosis.
Test Limitations: Specific to HbD; correlation with symptoms needed. False negatives possible with mixed variants.
References: ASH Guidelines, 2023; Blood, Itano HA, 2022.
